Generally, adiponectin is related to metabolic syndrome (insulin resistance, obesity, and dyslipidemia) in PCOS (42), which reflects the role of obesity in the mediation of adiponectin in PCOS. This evidence concerns the gene ADIPOQ and polycystic ovary syndrome.